Moneycontrol
HomeNewsBusinessStartupProsus India: PharmEasy and Eruditus deliver low returns; ElasticRun, Swiggy, PayU fare better in H1FY25
Trending Topics

Prosus India: PharmEasy and Eruditus deliver low returns; ElasticRun, Swiggy, PayU fare better in H1FY25

Prosus, which has invested over $8 billion in India over the years, said Meesho, BlueStone, PayU and Urban Company are all companies from its India portfolio that are likely to go public in the next 12-18 months, as the businesses mature.

December 02, 2024 / 14:33 IST
Story continues below Advertisement

Prosus and Naspers CEO Fabricio Bloisi

Online pharmacy startup, PharmEasy, continues to be a drag on Prosus’ India portfolio after it delivered an internal rate of return (IRR) of -38 percent (negative), the investor said in its half yearly (H1FY25) disclosures on December 2. Meanwhile, edtech company Eruditus had an IRR of 14 percent, among the lowest, filings showed.

Eruditus is however the only edtech that has delivered positive results for Prosus from its global portfolio. It has backed Byju's, Stack Overflow, Skillsoft and others.

Story continues below Advertisement

On the other hand, ElasticRun, the B2B e-commerce platform, delivered the highest IRR at 23 percent. Low value e-commerce company Meesho, fintech giant PayU and food tech company Swiggy all delivered an IRR of 20-21 percent each, Prosus said on December 2.

During the same period last year, PharmEasy had an IRR of -44 percent, Eruditus at 22 percent, ElasticRun at 31 percent, Meesho had an IRR 32 percent, PayU was at 30 percent and Swiggy had an IRR of 7 percent, respectively.